HOXC13 and central nervous system cancer: Upregulation of the expression of HOXC13-AS in hepatocellular carcinoma (Zhou J. F. et al., 2019), nasopharyngeal carcinoma (Gao et al., 2019), glioma (Liu et al., 2019), and intrahepatic cholangiocarcinoma (Angenard et al., 2019) indicates poor prognosis for patients.